前列腺癌中的正电子发射断层显像/计算机断层扫描（PET/CT）
PET/CT in Prostate Cancer.
作者信息
Evangelista Laura, Fanti Stefano
机构信息
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Italy.
IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.
出版信息
Cancers (Basel). 2023 Jul 25;15(15):3751. doi: 10.3390/cancers15153751.
Abstract
Over the last decade, PET/CT has played a crucial role in managing patients with prostate cancer (PCa), significantly impacting various aspects of the disease [...].
摘要
在过去十年中，正电子发射断层显像/计算机断层扫描（PET/CT）在前列腺癌（PCa）患者的管理中发挥了关键作用，对该疾病的各个方面产生了重大影响[...]。
相似文献
1
PET/CT in Prostate Cancer.前列腺癌中的正电子发射断层显像/计算机断层扫描（PET/CT）
Cancers (Basel). 2023 Jul 25;15(15):3751. doi: 10.3390/cancers15153751.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
The performance of F-PSMA PET/CT in the detection of prostate cancer: a systematic review and meta-analysis.F-PSMA PET/CT 在前列腺癌检测中的性能：系统评价和荟萃分析。
Asian J Androl. 2022 Jul-Aug;24(4):373-379. doi: 10.4103/aja202162.
4
[¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.[¹¹C]胆碱正电子发射断层扫描/计算机断层扫描（PET/CT）可预测根治性前列腺切除术后生化复发的激素初治前列腺癌患者的生存率。
Eur J Nucl Med Mol Imaging. 2015 May;42(6):877-84. doi: 10.1007/s00259-015-3015-8. Epub 2015 Feb 20.
5
Value of Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study.镓标记蛙皮素拮抗剂（RM2）在原发性前列腺癌检测中的价值：与[F]氟甲基胆碱 PET-CT 和多参数 MRI 的比较——一项 I/II 期研究。
Eur Radiol. 2023 Jan;33(1):472-482. doi: 10.1007/s00330-022-08982-2. Epub 2022 Jul 21.
6
Detection of prostate cancer with F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial.F-DCFPyL PET/CT 检测与根治性前列腺切除术标本最终组织病理学比较：PSMA 靶向活检是否可行？DeTeCT 试验。
World J Urol. 2021 Jul;39(7):2439-2446. doi: 10.1007/s00345-020-03490-8. Epub 2020 Oct 20.
7
Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis.前列腺癌原发和继发分期中 PSMA-PET/CT 的组织病理学验证诊断准确性及 PSMA-PET/CT 对临床管理的影响：系统评价和荟萃分析。
Semin Nucl Med. 2023 Sep;53(5):706-718. doi: 10.1053/j.semnuclmed.2023.02.006. Epub 2023 Mar 31.
8
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy.基线 PSMA-PET/CT 作为接受新辅助治疗的高危局限性非转移性前列腺癌患者根治性前列腺切除术后 PSA 持续存在的预测因子。
Prostate. 2023 Aug;83(11):1112-1120. doi: 10.1002/pros.24553. Epub 2023 May 10.
9
Diagnostic performance of Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms.镓-PSMA PET/CT 在前次前列腺活检前对前列腺癌的诊断性能：与预测癌症列线图的比较。
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):908-920. doi: 10.1007/s00259-018-4255-1. Epub 2019 Jan 11.
10
Comparison of Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA PET/CT）与多参数磁共振成像（MRI）在检测低危和中危前列腺癌中的比较。
EJNMMI Res. 2022 Feb 11;12(1):10. doi: 10.1186/s13550-022-00881-3.
引用本文的文献
1
F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients.F-FDG PET/CT影像组学分析及人工智能预测乳腺癌患者新辅助化疗后的病理完全缓解
Radiol Med. 2025 Apr;130(4):543-554. doi: 10.1007/s11547-025-01958-4. Epub 2025 Jan 28.
本文引用的文献
1
An Apparent Diffusion Coefficient-Based Machine Learning Model Can Improve Prostate Cancer Detection in the Grey Area of the Prostate Imaging Reporting and Data System Category 3: A Single-Centre Experience.基于表观扩散系数的机器学习模型可改善前列腺影像报告和数据系统3类灰色区域中的前列腺癌检测：单中心经验
Cancers (Basel). 2023 Jun 30;15(13):3438. doi: 10.3390/cancers15133438.
2
A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients.去势抵抗性前列腺癌患者PSMA PET/CT仅骨转移疾病发生率的回顾性多中心分析
Cancers (Basel). 2023 Apr 8;15(8):2208. doi: 10.3390/cancers15082208.
3
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with Ga-PSMA PET/CT Features in Primary Staging.高危前列腺癌患者的组织学及免疫组化中PSMA表达：与原发分期中Ga-PSMA PET/CT特征的比较
Cancers (Basel). 2023 Mar 10;15(6):1716. doi: 10.3390/cancers15061716.
4
Oligometastatic Prostate Cancer Treated with Metastasis-Directed Therapy Guided by Positron Emission Tomography: Does the Tracer Matter?正电子发射断层扫描引导下的转移灶定向治疗对寡转移前列腺癌的疗效：示踪剂有影响吗？
Cancers (Basel). 2023 Jan 3;15(1):323. doi: 10.3390/cancers15010323.
5
Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET.PSMA PET时代复发性和异时性寡转移性前列腺癌患者的管理
Cancers (Basel). 2022 Dec 15;14(24):6194. doi: 10.3390/cancers14246194.
6
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study.PSMA PET用于评估去势抵抗性前列腺癌患者的肝转移：一项多中心回顾性研究
Cancers (Basel). 2022 Nov 18;14(22):5680. doi: 10.3390/cancers14225680.
7
The Role of [Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review.[镓]PSMA PET/CT在既往活检结果为阴性或阳性的前列腺癌临床疑似患者中的作用：一项系统评价
Cancers (Basel). 2022 Oct 14;14(20):5036. doi: 10.3390/cancers14205036.
8
Radiomics Analysis on [Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.基于[镓]镓-PSMA-11 PET和MRI-ADC对前列腺癌国际泌尿病理学会（ISUP）分级进行预测的影像组学分析：BIOPSTAGE试验的初步结果
Cancers (Basel). 2022 Apr 8;14(8):1888. doi: 10.3390/cancers14081888.
9
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature.PSMA和胆碱PET用于评估前列腺癌患者的治疗反应和生存结果：文献系统评价
Cancers (Basel). 2022 Mar 31;14(7):1770. doi: 10.3390/cancers14071770.
10
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.欧洲药品管理局限制使用后，镭-223治疗的转移性去势抵抗性前列腺癌患者中BIO-Ra评分的预后价值：多中心BIO-Ra研究的二次调查
Cancers (Basel). 2022 Mar 29;14(7):1744. doi: 10.3390/cancers14071744.
Zotero 插件